(2R)-N-[4-chloro-3-[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]-3-oxopropyl]piperidin-4-yl]oxyphenyl]-2-[4-(6-fluoroquinolin-4-yl)cyclohexyl]propanamide

C49H53ClFN7O7 — CID 171833676

IUPAC(2R)-N-[4-chloro-3-[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]-3-oxopropyl]piperidin-4-yl]oxyphenyl]-2-[4-(6-fluoroquinolin-4-yl)cyclohexyl]propanamide
SMILESC[C@@H](C(=O)Nc1ccc(Cl)c(OC2CCN(CC(C=O)N3CCN(c4ccc5c(c4)C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)CC2)c1)C1CCC(c2ccnc3ccc(F)cc23)CC1
InChIInChI=1S/C49H53ClFN7O7/c1-29(30-2-4-31(5-3-30)37-14-17-52-42-11-6-32(51)24-39(37)42)46(61)53-33-7-10-41(50)44(25-33)65-36-15-18-55(19-16-36)27-35(28-59)57-22-20-56(21-23-57)34-8-9-38-40(26-34)49(64)58(48(38)63)43-12-13-45(60)54-47(43)62/h6-11,14,17,24-26,28-31,35-36,43H,2-5,12-13,15-16,18-23,27H2,1H3,(H,53,61)(H,54,60,62)/t29-,30?,31?,35?,43?/m1/s1
InChIKeyFNRONHDNWZQWEY-SNNDUKLCSA-N
MW906.46 g/mol
LogP6.21
Rot. Bonds12

About (2R)-N-[4-chloro-3-[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]-3-oxopropyl]piperidin-4-yl]oxyphenyl]-2-[4-(6-fluoroquinolin-4-yl)cyclohexyl]propanamide

(2R)-N-[4-chloro-3-[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]-3-oxopropyl]piperidin-4-yl]oxyphenyl]-2-[4-(6-fluoroquinolin-4-yl)cyclohexyl]propanamide (PubChem CID 171833676) has the molecular formula C49H53ClFN7O7 and a molecular weight of 906.46 g/mol. Its IUPAC name is (2R)-N-[4-chloro-3-[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]-3-oxopropyl]piperidin-4-yl]oxyphenyl]-2-[4-(6-fluoroquinolin-4-yl)cyclohexyl]propanamide.

Molecular Properties

Compound Name(2R)-N-[4-chloro-3-[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]-3-oxopropyl]piperidin-4-yl]oxyphenyl]-2-[4-(6-fluoroquinolin-4-yl)cyclohexyl]propanamide
PubChem CID171833676
Molecular FormulaC49H53ClFN7O7
Molecular Weight906.46 g/mol
Exact Mass905.37
IUPAC Name(2R)-N-[4-chloro-3-[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]-3-oxopropyl]piperidin-4-yl]oxyphenyl]-2-[4-(6-fluoroquinolin-4-yl)cyclohexyl]propanamide
SMILESC[C@@H](C(=O)Nc1ccc(Cl)c(OC2CCN(CC(C=O)N3CCN(c4ccc5c(c4)C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)CC2)c1)C1CCC(c2ccnc3ccc(F)cc23)CC1
InChIInChI=1S/C49H53ClFN7O7/c1-29(30-2-4-31(5-3-30)37-14-17-52-42-11-6-32(51)24-39(37)42)46(61)53-33-7-10-41(50)44(25-33)65-36-15-18-55(19-16-36)27-35(28-59)57-22-20-56(21-23-57)34-8-9-38-40(26-34)49(64)58(48(38)63)43-12-13-45(60)54-47(43)62/h6-11,14,17,24-26,28-31,35-36,43H,2-5,12-13,15-16,18-23,27H2,1H3,(H,53,61)(H,54,60,62)/t29-,30?,31?,35?,43?/m1/s1
InChIKeyFNRONHDNWZQWEY-SNNDUKLCSA-N
XLogP6.21
TPSA161.56 Ų
H-Bond Donors2
H-Bond Acceptors11
Rotatable Bonds12
Heavy Atoms65
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500906.46
LogP ≤ 56.21
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze (2R)-N-[4-chloro-3-[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]-3-oxopropyl]piperidin-4-yl]oxyphenyl]-2-[4-(6-fluoroquinolin-4-yl)cyclohexyl]propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R)-N-[4-chloro-3-[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]-3-oxopropyl]piperidin-4-yl]oxyphenyl]-2-[4-(6-fluoroquinolin-4-yl)cyclohexyl]propanamide?
The IUPAC name of (2R)-N-[4-chloro-3-[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]-3-oxopropyl]piperidin-4-yl]oxyphenyl]-2-[4-(6-fluoroquinolin-4-yl)cyclohexyl]propanamide (CID 171833676) is (2R)-N-[4-chloro-3-[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]-3-oxopropyl]piperidin-4-yl]oxyphenyl]-2-[4-(6-fluoroquinolin-4-yl)cyclohexyl]propanamide.
What is the SMILES notation for (2R)-N-[4-chloro-3-[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]-3-oxopropyl]piperidin-4-yl]oxyphenyl]-2-[4-(6-fluoroquinolin-4-yl)cyclohexyl]propanamide?
The canonical SMILES for (2R)-N-[4-chloro-3-[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]-3-oxopropyl]piperidin-4-yl]oxyphenyl]-2-[4-(6-fluoroquinolin-4-yl)cyclohexyl]propanamide is C[C@@H](C(=O)Nc1ccc(Cl)c(OC2CCN(CC(C=O)N3CCN(c4ccc5c(c4)C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)CC2)c1)C1CCC(c2ccnc3ccc(F)cc23)CC1.
What is the InChIKey of (2R)-N-[4-chloro-3-[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]-3-oxopropyl]piperidin-4-yl]oxyphenyl]-2-[4-(6-fluoroquinolin-4-yl)cyclohexyl]propanamide?
The InChIKey is FNRONHDNWZQWEY-SNNDUKLCSA-N. The full InChI is InChI=1S/C49H53ClFN7O7/c1-29(30-2-4-31(5-3-30)37-14-17-52-42-11-6-32(51)24-39(37)42)46(61)53-33-7-10-41(50)44(25-33)65-36-15-18-55(19-16-36)27-35(28-59)57-22-20-56(21-23-57)34-8-9-38-40(26-34)49(64)58(48(38)63)43-12-13-45(60)54-47(43)62/h6-11,14,17,24-26,28-31,35-36,43H,2-5,12-13,15-16,18-23,27H2,1H3,(H,53,61)(H,54,60,62)/t29-,30?,31?,35?,43?/m1/s1.
What are the key properties of (2R)-N-[4-chloro-3-[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]-3-oxopropyl]piperidin-4-yl]oxyphenyl]-2-[4-(6-fluoroquinolin-4-yl)cyclohexyl]propanamide?
(2R)-N-[4-chloro-3-[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]-3-oxopropyl]piperidin-4-yl]oxyphenyl]-2-[4-(6-fluoroquinolin-4-yl)cyclohexyl]propanamide has a molecular weight of 906.46 g/mol, XLogP of 6.21, 12 rotatable bonds, 2 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-N-[4-chloro-3-[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]-3-oxopropyl]piperidin-4-yl]oxyphenyl]-2-[4-(6-fluoroquinolin-4-yl)cyclohexyl]propanamide is sourced from PubChem (CID 171833676), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).